Sao Paulo Hosts Second CPhI and P-MEC South America Pharma Events
MAARSSEN, Netherlands, Aug. 6 /PRNewswire/ -- Against the background of continuing strong market growth, Sao Paulo will host the second CPhI South America and P-MEC South America pharma
ingredients and production technology events on Wednesday 26 - Friday 28 August.
Staged by UB...
China Pharma Events Keep Growing For UBM
MAARSSEN, The Netherlands, Aug. 6: /PRNewswire/ -- Numbers were impressive at June's CPhI China , with ICSE China and P-MEC China - which together form Asia 's biggest annual networking opportunity for the pharma
ingredients, services and production equipment communities. ...
MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT
Sciele Pharma, Inc., a Shionogi Company, today announced the availability
of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription
medication that kills head lice by asphyxiation without potential neurotoxic
side effects. Approved by the U.S. Food & Drug Administration (FDA),...
URL Pharma Acquires PharmPro Manufacturing Facility and Equipment
PHILADELPHIA, Aug. 3 /PRNewswire/ -- URL Pharma, a leading specialty pharmaceutical company, today announced it has acquired the assets of PharmPro, a division of Fluid Air, Inc. The facility, located in Aurora, Illinois, is FDA inspected and DEA (Drug Enforcement Agency) licensed. The ...
China Pharma Holdings, Inc. to Report Second Quarter 2009 Financial Results on August 12, 2009
HAIKOU CITY, China, July 29 /PRNewswire-Asia-FirstCall/ -- China Pharma
Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops,
manufactures, and markets specialty pharmaceutical products in China, today
announced that it plans to release second quarter 2009 financial resul...
aTyr Pharma Raises an Additional $12 Million
SAN DIEGO, July 28 /PRNewswire/ -- aTyr Pharma
announced today that it has raised an additional $12 million to fund its discovery operations and development of its lead candidate. The company is discovering and developing biotherapeutics to treat a wide variety of diseases, includi...
Avidas(TM) Pharmaceuticals and LaRon(TM) Pharma Inc. Announce Co-Promotion Agreement
DOYLESTOWN, Pa., July 21 /PRNewswire/ -- Avidas Pharmaceuticals and LaRon Pharma
Inc. today announced that they have entered into an agreement for LaRon to co-promote Avidas' key prescription-only convenience kits, Avidoxy(TM) DK defence kit and Scalacort(TM) DK defence kit. Under the te...
Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary
DOYLESTOWN, Pa., July 10 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that Dr. Richard Rosenbloom has resumed providing services to the Company's Quigley Pharma
subsidiary. Dr. Rosenbloom had been temporarily suspended from t...
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
Services to Focus on the Delivery of Early Stage Services -
Discovery Through Phase IIa
TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ ), a leading provider of products and services to the global life sciences markets, today announced that it has...
Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner;
Award Recognizes Entrepreneurial Excellence
LAWRENCEVILLE, N.J., June 30 /PRNewswire/ -- Aton Pharma, Inc. announced today that its Chief Executive Officer, Michael G. Wells, has received the Ernst & Young Entrepreneur Of The Year (R) 2009 Award in the emerging companies category in New ...
Pharma in Medical Technology
New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects
LEIDEN, The Netherlands, July 6 /PRNewswire/ -- Three new small and
medium sized enterprises (SMEs) - Syncom, Synvolux Therapeutics and InteRNA
Technologies - have joined public-private partnership TI Pharma
participating in two new projects. These projects, focusing on cancer and
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma
Ltd., a privately
held drug development company with its headquarters in Turku, Finland,
announced positive results from its Phase IIa clinical trial of ProtoCure(TM)
emulsion cream, the company's novel topical drug for dermatology. This
PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans
MONTEREY, Calif., June 2 /PRNewswire/ -- This month's Journal of Aerosol Medicine and Pulmonary Drug Delivery features positive Phase Ib clinical trial results for PARI Pharma's L-CsA, inhaled liposomal cyclosporine A. In May, PARI Pharma
received Orphan Drug Designation from the Food and Drug Ad...
BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
TURKU, Finland, May 28 /PRNewswire/ -- BioCis Pharma
privately-held drug development company with its headquarters in Turku,
Finland, has started Phase I clinical testing of ProtoCure(TM) intravesical
instillation solution, a novel anti-cancer drug for urinary bladder cancer.
Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
- The company plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration in 2010 -
SAN FRANCISCO, May 20 /PRNewswire/ -- Dainippon Sumitomo Pharma
Co., Ltd., (DSP) announced today positive results from the first phase 3 clinical trial for lurasidone, which is under ...
Tris Pharma Announces Acceptance of Its First Two NDAs
- First ever 24 hour oral liquid sustained release formulation submitted to the FDA
- Validates OralXR(TM) technology platform - eliminates the need to swallow pills by providing sustained release in liquids, chewable tablets, and films
- Upon approval will provide both liquid and tablet...
Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG
ZURICH, Switzerland, April 30 /PRNewswire/ -- An innovative treatment for
infections of the respiratory tract in cystic fibrosis patients has received
orphan drug designation in the US. Axentis Pharma
of Zurich, Switzerland
announced today that this sought-after designation has been granted to...
Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
EVRY, France, April 15 /PRNewswire/ -- Novagali Pharma, a French
pharmaceutical ophthalmic company, today announces successful completion of a
new Phase II clinical study with Cyclokat(R), its formulation of
Cyclosporine. The results demonstrate statistically significant improvement
Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma
EVRY, France, February 27 /PRNewswire/ -- Novagali Pharma, a French
pharmaceutical ophthalmic company, announced the results of its first set of
data pertaining to Nova21027, its innovative BAK-free latanoprost formulation
Novagali communicated about "Ocular safety compari...
Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
READING, England, February 26 /PRNewswire/ --
- Intranasal Apomorphine for the Treatment of Motor Fluctuations in
Advanced Parkinson's Disease
- Intranasal Diazepam for the Treatment of Acute Repetitive Seizures in
- Phase II Trials on Both Projects to be Initiate...
Pharma in Biological News
Boost from McGill, Gates Foundation helps Africans control pharma research
This release is available in French .
A McGill University parasitology researcher has received a $100,000 grant from the Gates Foundation to help establish locally controlled pharmaceutical-research programs in Botswana and South Africa.
"People are always asking why the pharmaceutica...
Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc.
A business success story has both UCLA and a team of enterprising UCLA scientists envisioning a brighter future for cancer research and patient care.
In 1996, a unique collaboration of leading UCLA scientists led by Dr. Arie Belldegrun founded the biotechnology company Agensys Inc. and the c...
Martin Hensen, head of e-strategies, UCB Germany: Making e-marketing more than just an add-on
..., reminds him of Web 2.0. But he questions whether pharma
is ready for Web 2.0.
The health system is 100% regulated, Hensen says, making it Health 1.0. But pharma
itself is no better. He says with content needing ...sites and more people in Legal than in e-Business, pharma
companies themselves are still at...
DuoCort: New chronotherapy for adrenal insufficiency
... the USA. The new product, a once daily dual-release hydrocortisone oral tablet that comes in both 5 mg and 20 mg sizes, is being developed by DuoCort pharma
AB, a wholly-owned subsidiary. For more information on DuoCort please visit www.duocort.com Contact information Medical spokesperson: Gudmundur Joh...
New supplement may help slow sight loss in elderly
...he advice of Professor Ian Young from the School of Medicine, Dentistry and Biomedical Sciences at Queen's and scientists in eyecare companies Dr Mann pharma
and Bausch and Lomb.
AMD is an incurable eye disease which causes blurring of central vision because of its effects on the macula, the central part ...
Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
...ders. The base of Amarna’s therapeutics is the SVac viral gene delivery vector platform, which provides sensational characters unheard of in the pharma
arena, creating opportunities to serve markets with enormous potential due to clinical unmet needs.
Our SVac viral gene delivery vec...
American Chemical Society's Weekly PressPac -- May 20, 2009
...ent. No drug companies lost money, but double digit earnings declines at some top firms raised warning flags. For a free copy of this C&EN story about pharma
companies' economic problems, send an e-mail to email@example.com .
ACS pressroom blog
The American Chemical Society's Office of Public Affai...
Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
...and other jurisdictions.
MixJect® is a registered trademark of Medimop Medical Projects Inc.
For more information contact
phone: +49-(0)751-3700 - 0
fax: +49-(0)751-3700 - 40 00
Former NASA astronaut Bonnie J. Dunbar to speak at NJIT's biomedical engineering seminar
...to the world of flight.
The event will be held at 11:30 a.m., on Thursday, April 23, 2009, in 118 Kupfrian Hall. Event sponsors include Purdue pharma
L.P. and Bristol-Myers Squibb Company.
Dr. Bonnie J. Dunbar is currently president and CEO of The Museum of Flight in Seattle,Washington. The "MOF"...
In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter
... the 343 companies in attendance, including 11 big pharma
companies, held some 2,500 business meetings. The ...difficult economic context by offering biotech and pharma
company managers a solid chance to develop busines...ncreasingly high-performance diagnostic tools. The pharma
industry and the biotechs are therefore working to...
Pharma in Biological Technology
Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
PRINCETON, N.J., July 28 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Daniel E. Leone as Vice President of Business Development. Mr. Leone will be responsible for Laureate's worldwid...
Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
London, July 20 /PRNewswire/ -- There has been a recent upsurge in Merger & Acquisition (M&A) activities in the pharmaceutical and biotechnology space. While the economic downturn and related credit crunch has had an impact, this alone cannot account for the recent M&A mania,...
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
HORSHOLM, Denmark, July 14 /PRNewswire/ -- The Board of Directors of
has approved the Interim Report for the period 1 January to
30 June 2009.
- The loss after tax realised in the 2nd quarter of 2009 was
21,6m DKK (2,9m EUR) compared to 29,8m DKK (4,0m EUR) in the...
Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
ST PETER PORT, Guernsey and LONDON, July 6 /PRNewswire/ --
- GBP13.1 Million Funding to Drive Novel Antibiotics Platform Addressing
Areas of Major Unmet Need, Including Hospital Acquired Infections C.
Difficile and MRSA
Holdings Advisors LLP ("CPHA"), the advisor to...
Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
OSLO, Norway, June 26 /PRNewswire-FirstCall/ -- Clavis Pharma
CLAVIS) today announced that the Company has raised NOK 129 million
(equivalent to USD 20 million) in gross proceeds through a private placement
of 10,750,000 new shares, each with a par value of NOK 1.00 at a price of NOK...
Dragon Pharma Announces Results of 2009 Annual General Meeting
VANCOUVER, June 22 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced the results of the Annual Shareholders Meeting held on June 21, 2009 in Hong Kong, China.
Mexico Premiere for Money-Saving Pharma Leak Testing Equipment
Sepha Ltd's ergonomically designed leak testing machines for the Central American pharmaceutical packaging industry makes premiere appearance at Expo Pack 2009, Mexico City on 23-26 June. BLISTERSCAN, PRESS-OUT UNIVERSAL and PRESS-OUT MANUAL will be in action at Expo Pack and the Sepha team w...
Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder
Research Published by Scripps Associate Professor Xiang-Lei Yang Further Validates aTyr Pharma's Discovery Engine for Proprietary Drugs
SAN DIEGO, June 8 /PRNewswire/ -- The June 1st, 2009 edition of The Scripps Research Institute (TSRI) News & Views highlights newly published researc...
Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
COPENHAGEN, June 3 /PRNewswire/ -- Santaris Pharma
Institute of Technology, Aalborg University, Denmark, announced today that
Director of microRNA, Santaris Pharma, Sakari Kauppinen, has been appointed
Adjunct Professor in RNA Biology at Copenhagen Institute of Technology. The
2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
LONG BRANCH, N.J., June 3 /PRNewswire/ -- The 2009 Pharma
ChemOutsourcing Conference & Exhibition attendance is way up again in 2009 and is poised to shatter the attendance record set in 2008. The remarkable success of last year's meeting generated the positive buzz responsible for much of th...
Pharma in Biological Definition
...a are under development, with no completely effective vaccine yet available (as of November 2004 ). A team backed by the Gates Foundation and the pharma
giant GlaxoSmithKline announced a partially successful field trial in October 2004 , for RTS,S/AS02A , a vaccine which reduces infection risk by...
Pharma in Biological Dictionary
...es. 5 External links ... Retrieved from "http://en.wikipedia.org /wiki/ Dendrite " ... Cegedim Dendrite is the worldwide leader in pharma
CRM and Data Solutions for the Pharmaceutical Industry. ... Cegedim Dendrite's Laurent Schockmel Named to ... (Click to enlarge) dendrite ( Sch...
...aves the regulatory site . ... Allosteric Site - BioPortfolio - Indepth ... Biochemistry: Jul 13 2009 5:03PM Matching: allosteric site ... pharma
Live: Jun 29 2009 8:58AM Matching: allosteric site ... ALLOSTERIC SITE OF SCCM. CONFORMATIONS OF SCCM ... UTP can bind to the allosteric ...